February 2025: Unlocking Cancer’s Secrets: Prof. Uri Ben-David on "TAU Unbound"
In TAU Unbound, a joint podcast with the Jerusalem Post, host Ido Aharoni interviewed Prof. Uri Ben-David, Edmond J. Safra member (Medicine), a leading cancer researcher at TAU.
In a compelling episode of TAU Unbound, a joint podcast with the Jerusalem Post, host Ido Aharoni interviews Prof. Uri Ben-David, Edmond J. Safra member (Medicine), a leading cancer researcher at TAU. His lab focuses on aneuploidy—an abnormal number of chromosomes in cancer cells—an understudied but crucial aspect of tumor development.
Ben-David discusses how aneuploidy influences cancer evolution and the need for multiple targeted treatments rather than a single cure, as cancer is a complex family of diseases. He also highlights the rise of precision medicine, where advances in genetics and AI are paving the way for personalized cancer therapies based on a tumor’s unique DNA profile.
This episode sheds light on cutting-edge cancer research, bridging the gap between scientific discovery and innovative treatments.
Related Articles
